#advance catheter extrusions

[ultirapid]

Injection Molding for Medical Device Parts: Pursuing Excellence to Ensure Health and Safety

Medical plastic components are vital to the healthcare industry. They are widely used in the production of medical devices, instruments, and tools essential for diagnosing, treating, and monitoring patients. These parts are generally made using injection molding technology, which ensures high standards of quality and safety through strict adherence to industry standards.

I. Injection Molding: The Tool for Shaping Medical Parts

Injection molding is a process where molten plastic is injected into molds to create parts that then cool and solidify into the desired shape. This technique is crucial in manufacturing medical components due to its precision and versatility.

II. Common Injection Molding Techniques: Meeting Diverse Needs

There are several types of injection molding processes that cater to various medical part requirements:

Standard Injection Molding: The basic method where molten plastic is injected into a mold to form the part.

Insert Molding: Metal or other materials are placed into the mold before injecting plastic, which integrates these inserts into the final part, enhancing its functionality.

Overmolding: This technique combines two different materials or colors into one part, improving its appearance and functionality.

Microcellular Foam Injection Molding: Gas is injected into the plastic to create a foam structure, which reduces the part’s weight and enhances its performance.

Nano Injection Molding: Uses nanotechnology to fuse plastic and metal into a single, sturdy part.

Blow Molding: Ideal for producing hollow medical containers and tubing.

Extrusion Molding: Used to create continuous plastic profiles, such as medical catheters.

III. Applications of Injection Molding in Medical Parts: Protecting Health

Injection molding technology is essential for producing various medical components:

Medical Device Casings and Components: Includes housings, panels, buttons, and connectors that ensure the proper functioning and ease of use of medical devices.

Syringe and Infusion Set Parts: Such as plungers, barrels, and connectors, which are crucial for precise drug delivery and patient safety.

Respiratory Devices: Includes respirators and oxygen masks, which require high standards of sealing and hygiene.

Medical Containers: Plastic containers, bottles, and packaging for drugs and reagents, ensuring safe storage and transport.

Dental Equipment: Includes items like impression trays and braces, designed to meet specific dental treatment needs.

Surgical Tools: Includes handles and grips for surgical instruments, requiring ergonomic design and biocompatible materials.

IV. Choosing a Medical Parts Injection Molding Factory: Quality Comes First

Selecting the right factory for medical parts injection molding is crucial. Consider the following factors:

Certification: Choose a factory with ISO 13485 certification, which ensures compliance with quality management standards for medical devices.

Experience and Technology: The factory should have extensive experience in medical injection molding and advanced technology to meet custom needs.

Project Support and Communication: The factory should provide expert project support and maintain clear communication to ensure smooth project execution.

V. The Importance of Quality in Medical Injection Molding: The Cornerstone of Health

The quality of medical injection-molded parts is critical for patient safety and the overall health of the healthcare industry. High-quality parts help reduce risks, improve treatment outcomes, and build patient trust, adding significant value for medical device manufacturers.

AbleMed brings extensive experience in medical injection molding, strictly adhering to ISO 13485 standards. Our skilled engineering team provides expert advice and project support, helping clients bring their medical products to market quickly and cost-effectively with high-quality solutions.

Frequently Asked Questions

What materials are used in medical injection molding? Medical injection molding typically uses medical-grade plastics such as polypropylene (PP), polyethylene (PE), polycarbonate (PC), and polyether ether ketone (PEEK), as well as high-performance polymers like ETFE and PPSU, to meet various application needs.

What standards and regulations apply to medical injection molding? Medical injection molding must comply with international and regional standards and regulations, including ISO 13485:2016 (Medical Device Quality Management Systems) and FDA regulations, to ensure product safety and effectiveness.

[medicaltechnologies]

ABOUT ANJUN

Anjun Medical Technologies (Suzhou) Co., Ltd. was established in 2008 and is a manufacturer specializing in the research and development, production, and sales of medical catheters. The company has passed the ISO13485 system certification, with a "Class 10000 cleanroom" of 800 square meters and a standard medical device production plant of 3000 square meters. The company currently has multiple advanced medical catheter extrusion production lines, precision processing workshops, injection molding workshops, and assembly workshops, as well as well-equipped post-processing equipment and sophisticated and complete inspection equipment. Combining its technical advantages, the company aims to achieve more competitive products and services for customers.

[tamanna31]

Medical Plastics: Industry Dynamics, Major Companies Analysis and Forecast- 2030

Medical Plastics Industry Overview

The global medical plastics market size was estimated at USD 52.9 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030.

This growth can be attributed to the development of advanced plastics and plastic composites used in medical components such as catheters, surgical instrument handles, and syringes. The demand for medical device packaging is likely to be driven by a rise in demand for in-house and advanced medical devices. Plastics including polyethylene, polypropylene, and polycarbonate are increasingly being utilized for the manufacturing of medical devices. The growth of home healthcare due to its low costs compared to hospital care and intensive care has resulted in a rise in demand for medical devices.

Gather more insights about the market drivers, restrains and growth of the Medical Plastics Market

According to the latest U.S. census, 16.8% of the U.S. population is over the age of 65 years and this number is anticipated to reach 74 million by 2030. People aged over 85 need the most care and their population is growing rapidly. In March 2021, the U.S. President, Joe Biden, proposed spending USD 400 billion on Medicaid over eight years to fund at-home care for elderly and disabled people as well as increase the wages of caregivers.

In the U.S., the frequent increment in costs and reduced margins have severely impacted healthcare providers and health plans. This compelled the government to ensure a significant transformation of healthcare funding and insurance coverage segments in the country through the introduction of ACA and Medicaid.

The COVID-19 pandemic has made in-home care more appealing than nursing home facilities as home care reduces healthcare costs and is more convenient for patients. According to Medicaid and CHIP Payment and Access Commission (MACPAC), it costs about USD 26,000 a year for home care compared to USD 90,000 a year for a nursing home. Increasing investment in healthcare by the government and rising preference for home care are expected to drive the medical plastics market in the U.S. over the forecast period.

The presence of key manufacturers such as Dow, Inc., Eastman Chemical Co., and DuPont can be regarded as one of the major factors driving the market for medical plastics in the country.

Browse through Grand View Research's Plastics, Polymers & Resins Industry Research Reports.

• The global wood pallets market size was estimated to be USD 13.12 billion in 2023, growing at a CAGR of 4.5% from 2024 to 2030.

• The global food wrap market size was estimated at USD 5.15 billion in 2023 and is projected to grow at a CAGR of 7.5% from 2024 to 2030.

Global Medical Plastic Market Report Segmentation

This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medical plastic market report based on product, application, and region.

Product Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)

Polyethylene (PE)

Polypropylene (PP)

Polycarbonate (PC)

Liquid Crystal Polymer (LCP)

Polyphenylsulfone (PPSU)

Polyethersulfone (PES)

Polyethylenimine (PEI)

Polymethyl Methacrylate (PMMA)

Others

Process Technology Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)

Extrusion

Injection Molding

Blow Molding

Other

Application Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)

Medical Device Packaging

Medical Components

Orthopedic Implant Packaging

Orthopedic Soft Goods

Wound Care

Cleanroom Supplies

BioPharm Devices

Mobility Aids

Sterilization and Infection Prevention

Tooth Implants

Denture Base Material

Other Implants

Others

Region Outlook (Volume, Kilotons & Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Italy

Netherland

Asia Pacific

China

India

Japan

Central & South America

Brazil

Argentina

Middle East & Africa

Saudi Arabia

UAE

Key Medical Plastics Company Insights

Some key market players include BASF SE; Celanese Corporation; Evonik Industries AG; SABIC; Dow, Inc.; Solvay S.A.; Trinseo S.A.; and Eastman Chemical Company.

Key Medical Plastics Companies:

The following are the leading companies in the medical plastics market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these medical plastics companies are analyzed to map the supply network.

Röchling SE & Co. KG

Nolato AB

Saint-Gobain

SABIC

Orthoplastics Ltd

Eastman Chemical Company

Celanese Corporation

Dow, Inc.

Tekni-Plex, Inc.

Solvay S.A.

HMC Polymers Company Limited

ARAN BIOMEDICAL TEORANTA

Trelleborg Group

Avantor, Inc.

Trinseo

Evonik Industries AG

Recent Developments

Some key players operating in market include BASF SE; Celanese Corporation; Evonik Industries AG; SABIC; Dow, Inc.; Solvay S.A.; Trinseo S.A.; Eastman Chemical Company among others.

In February 2023, Cleanse Corporation announced the acquisition of DUPONT's mobility and mobility business for USD 11.00 billion. This strategic move enables Cleanse to expand its global reach and enhance its offerings in the environmental sector, particularly in sustainable transportation.

In June 2023, SABIC acquired Clariant's 50% stake in Scientific Design, a renowned catalysis leader. This acquisition bolstered the non-cyclical, technology-driven business and brought it closer to becoming a leading global specialist

Order a free sample PDF of the Medical Plastics Market Intelligence Study, published by Grand View Research.

[helthcareheven]

From Concept to Cure: The Evolution of Medical Plastics

Overview of Medical Plastics

Medical plastics have become ubiquitous in healthcare applications over recent decades. A wide range of polymers are now used in everything from surgical tools and medical devices to implants, prosthetics, and diagnostic equipment. Some key advantages of plastics for medical applications include their lightweight nature, durability, biocompatibility, and flexibility in design and manufacturing. This article provides an overview of common medical plastics and their uses in modern patient care.

Thermoplastics in Surgical Tools and Medical Devices

Thermoplastics like polyvinyl chloride (PVC) and polyolefins are widely employed in disposable medical tools and devices. These plastics can be easily shaped, formed, and sealed through heating and cooling processes like injection molding and extrusion. Common thermoplastic applications include surgical drapes, gowns, gloves, face masks, catheters, tubing, syringes, and many other single-use items. Thermoplastics offer sterilizability, low cost, and convenience as they can be produced quickly and disposed of after a single use, reducing risks of cross-contamination compared to reusable materials.

Thermoplastics are also used to construct housings and components of more complex medical devices like dialysis machines, ventilators, ultrasound probes, endoscopes, and surgical tools. Their material properties allow intricate geometries to be replicated precisely while withstanding regular cleaning and sterilization cycles. Polycarbonate and acrylic thermoplastics often feature in medical device and equipment construction due to their transparency properties as well.

Engineering Plastics for Implants and Prosthetics

Engineering plastics with advanced material qualities have enabled new frontiers in medical implants and prosthetics. Ultra-high molecular weight polyethylene (UHMWPE) exhibits high strength and wear resistance essential for articulating joint replacements like knees, hips, and shoulders. Since its introduction, UHMWPE has vastly improved implant service lifetimes and mobility for millions worldwide.

Polyetheretherketone (PEEK) possesses radiolucency, making it well-suited for spinal and cranial implants. Its elastic modulus closely matches bone to minimize stress shielding while exhibiting biocompatibility and fatigue resistance. Titanium alloy and stainless steel bone screws, plates and rods are also widely employed in orthopedic and trauma surgery for strength and compatibility with scans.

Meanwhile, thermoplastic elastomers like polyurethanes facilitate lifelike prosthetics with soft tissue properties and resilience. Silicone formulations provide a barrier while transmitting sensory feedback in advanced prosthetic sockets and sleeves. Such optimized plastics enable unprecedented functionality and quality of life restoration for individuals with missing or non-functioning anatomy.

Diagnostic Equipment and Accessories

Diagnostic imaging modalities heavily rely on plastics to construct vital optical, electronic and mechanical systems. Liquid crystal polymers maintain precision tolerances in ultrasound transducer arrays and fiber optic cabling while withstanding stringent sterilization. Epoxy molding compounds encapsulate sensitive circuitry within CT and MRI scanners in protective housings.

Acrylic sheet forming finds use manufacturing view boxes and light boxes in radiology departments as the material effectively diffuses transmitted light for image analysis. Meanwhile polycarbonate excels as a housing material for portable ultrasound carts, endoscopy towers and lab equipment given its impact resistance, clarity and ease of disinfection. An assortment of commodity plastics from polypropylene to nylon further serve construction of trays, stands, handle grips and miscellaneous accessories throughout diagnostic settings.

Labware, Filtration and Storage

Plastics dominate the production of labware, filters and consumable storage products essential for diagnostic testing and biomedical research. Polypropylene and polyethylene provide an optimal combination of clarity, low bind-in, autoclavability and cost effectiveness for lab bottles, flasks, Petri dishes, microtubes, pipette tips and more. These widely inert plastics minimize risk of compound interactions.

Nylon and polycarbonate reinforce syringes and lab centrifuge containers against high speeds and mechanical stresses. PTFE and PVDF excel as biomaterial compatible membrane choices for important separations in areas like dialysis, blood filtration and cell culture. Meanwhile, plastics like PET and HDPE offer practical sterile storage and transportation solutions for reagents, blood products and clinical specimens with excellent barrier properties.

Future Outlook

Advancements in polymers and manufacturing technologies will undoubtedly yield further medical product innovations to come. Areas of active R&D include smart plastics possessing sensing, actuating and communication abilities for integrated diagnostics. 3D printed personalized implants fabricated from biodegradable polyesters address shortages while minimizing invasive surgery. Tissue engineering scaffolds may someday harness biopolymers ability to encourage natural regeneration. Always guided by principles of biocompatibility and sterility, medical plastics will remain at the forefront of patient care improvement for generations to come.

[chemicalresearchupdates]

Exploring the Dynamics of the Medical Polymers Market: A Comprehensive Industry Overview

The Medical Polymers Market is estimated to be valued at US$ 22.13 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:

Medical polymers are used in various medical devices, kits, implants and consumables due to their superior mechanical properties, chemical resistance and compatibility with human tissues. Some key properties of medical polymers include biocompatibility, flexibility and durability. They are used to manufacture medical equipment such as catheters, surgical gloves, syringes, prosthetics and more. Polymers offer advantages like transparency, lightweight and durability required for medical components. Market Key Trends:

Demand for biodegradable polymers is increasing due to strict environmental regulations regarding disposal of conventional polymers. Biodegradable polymers such as polylactic acid (PLA) and polyglycolic acid (PGA) are gaining popularity as they can decompose in soil or water and do not leave any toxic residue. They are used in sutures, tissue engineering scaffolds and drug delivery systems as an alternative to traditional polymers. Researchers are also developing new biodegradable polymers derived from natural polymers like cellulose, collagen and silk, to reduce ecological footprint of medical polymers. Adoption of eco-friendly biodegradable polymers will be a major trend in the medical polymers market over the forecast period.

Porter’s Analysis:

Threat of new entrants: Low barriers to entry for starting new businesses in medical polymers. However, established brands have predominant market share and resources.

Bargaining power of buyers: Large medical device manufacturers have significant bargaining power due to their volume purchases. They can negotiate on price and demand high quality products.

Bargaining power of suppliers: A few major companies dominate the supply of key polymers like PEEK, PP, silicone etc. This gives them strong bargaining power over customers.

Threat of new substitutes: New biodegradable materials are emerging but compatibility issues and regulatory approvals are barriers. Traditional polymers still have advantages of durability and processing flexibility.

Competitive rivalry: Intense competition amongst key players to develop application-specific polymers and bundles of products and services. Capital investments in R&D are high.

SWOT Analysis:

Strength: Wide range of properties to suit diverse medical device needs. Processability into complex shapes using injection moulding or extrusion. Resistance to chemicals, sterilization and prolonged exposure in bodily tissues or fluids.

Weakness: Concerns over toxicity of certain additives and plasticizers used. Regulatory compliance adds to production costs. Limited capability for large-scale personalization.

Opportunity: Growth in implantable devices, surgical tools and diagnostics. Rising healthcare access in developing nations. Development of bio-based and resorbable materials.

Threats: Stringent regulatory norms. Shift to localized manufacturing may impact multinational firms. Developing substitutes like bioplastics.

Key Takeaways

The global medical polymers market is expected to witness high growth exhibiting CAGR of 10% over the forecast period, due to increasing demand for improved implant materials and single use surgical and medical devices. The market size for 2023 is estimated at US$ 22.13 Bn. The North America region currently dominates the medical polymers market share due to presence of major players and advanced healthcare infrastructure. Asia Pacific is projected to be the fastest growing region owing to increasing healthcare investments, lower production costs and rising medical tourism. Key players operating in the medical polymers market are BASF SE, Bayer MaterialScience AG, Celanese Corporation, DSM N.V., E. I. du Pont de Nemours Company, Eastman Chemical Company, ExxonMobil Corporation, Evonik Industries AG, and The Dow Chemical Company. These established brands continuously invest in product development to widen their portfolios and adapt to evolving regulatory standards.

[kunalcmi]

MEDICAL PLASTIC EXTRUSION MARKET ANALYSIS - (2018-2026)

The medical plastic extrusion is a high volume manufacturing process in which raw plastic is melted and formed into the continuous profile using pellets, granules, and flakes powders with some additives such as colorants in either liquid or pellet form. It produces devices such as catheters, intravenous and drainage tubing, needle and syringe caps, injections, and other kind of components or devices that require profiled tube or shaft. Poly Vinyl Chloride (PVC) is the leading polymer used for medical tubing with polyurethane, polyolefin, and blends and alloys such as thermoplastic elastomer. Thus, medical plastic extrusion manufacturers set new production and quality expectations for the essential products like catheters, intravenous and drainage tubing for the medical departments.

 Medical Plastic Extrusion Market- Dynamics

The development in medical plastic extrusion technology and increase in new market players are the major driving factors of global medical plastic extrusion market. Increased access to healthcare services for consumers is also driving growth of the market.

Increasing cardiovascular diseases such as cardiac arrest, cardiac arrhythmia, and congestive heart failure will boost the demand for catheters, globally. On May 17, 2017, the World Health Organization (WHO) stated that the cardiovascular diseases (CVDs) are the number one cause of death, globally. WHO further stated that between 2013 and 2016, 121.5 million American adults were affected by CVDs. In 2016, coronary heart disease (43.2%) was the leading cause of death in the U.S. It will boost the medical plastic extrusion market. North America region, Europe suffers from urology diseases and growing geriatric population, which contributes to broad catheter market. The key factors driving growth of global medical plastic extrusion market include increase in number of surgical processes and growing applications in pain management.

 Medical Plastic Extrusion Market- Regional Dynamics

Regional segmentation of the global medical plastic extrusion by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in global medical plastic extrusion market over the forecast period. Medical plastic extrusion is widely used in hospitals, clinics, and other fields. The North America region launched the new moulding machines by using the plastic extrusion processes which particularly focused on the production capacity, supply and demand statistics, consumption, and volume of the medical plastic extrusion product. For instance, in 2017, Milacron Holdings Corp., a company serving the plastic processing industry launched a new Quantum Toggle injection moulding machine that further provides the features such reduced energy consumption and lowered cycle time coupled with precision and reliability. The Quantum Toggle injection machine is built to have higher productivity, reduced cost of ownership, and improve the performance and advanced technical specification.

 Medical Plastic Extrusion Market- Competitive Analysis

Key players in the global medical plastic extrusion market have inked cooperation agreement for strategic partnership for enhancing the quality of output with better design and manufacturing capabilities which is important for them and their customers, thereby augmenting the market growth. For instance, on October 27, 2016, Kabra Extrusion technik announced a strategic partnership with Unicor GmbH to provide fully integrated extrusion solutions and for the advanced extrusion design. Similarly, on February 18, 2019, Reifenhhauser Group acquired Plamex Maschinenbau GmbH, a move is designed to strengthen the medical plastic industry. Based in Kelberg, Germany, Plamex is a supplier of blown film lines and extrusion components, with core competencies in water cooled oriented films for medical industry.  Post-acquisition, it will work closely with Reifenhhauser Group for supplying the tailor made solutions for packaging industry. As a result, the Reifenhhauser Group will gain the access to new technology for flexible film production, leads to expand the blown film capabilities. After the acquisition, the group can now offer the technologies like water quench, double or multi bubble technologies to new customer group.

The key players in global medical plastic extrusion market are Fluortek, Ace, Putnam Plastics, Vesta, Teel Plastics, Raumedic, Biomerics, Vention medical, Pexco, and VistaMed.

 Request Sample Free Copy of Report here: https://www.coherentmarketinsights.com/insight/request-sample/2620

Download PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2620

 Medical Plastic Extrusion Market- Market Taxonomy

 On the basis of product type, the global medical plastic extrusion market is segmented into:

Medical Coextrusion

Multi Lumen Tubing

Thermoplastic Elastomer Tubing

Medical Tubing

Radiopaque fillers

Splittable Tubing

Etched liners

Others

 On the basis of materials, the global medical plastic extrusion market is segmented into:

Polystyrene

Acrylonitrile Butadiene Styrene

Polypropylene

Poly Vinyl Chloride

Others

 On the basis of application, the global medical plastic extrusion market is segmented into:

Hospitals

Clinic

Others

 On the basis of region, the global medical plastic extrusion market is segmented into:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

  Buy now the market research report here:

https://www.coherentmarketinsights.com/insight/buy-now/2620

  About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

Customized Market Research Services

Industry Analysis Services

Business Consulting Services

Market Intelligence Services

Long term Engagement Model

Country Specific Analysis

Explore CMI Services here

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Source: https://www.coherentmarketinsights.com/ongoing-insight/medical-plastic-extrusion-market-2620

[researchupdates]

Deflectable Catheters Market: Detailed analysis of current Industry figures with forecast growth by 2028

Overview of the Global Deflectable Catheters Market:

The large scale Deflectable Catheters Market report sheds light on each region, Market size in terms of (USD Mn) for every individual segment and their sub-segment for the period from 2021 to 2028, considering the macro and micro situation factors. The document gives a brief introduction to the research report outlook, TOC, list of tables and figures, an outlook to key players of the Market and comprising key regions. Additionally, the wide ranging Deflectable Catheters Market report helps the manufacturer in finding out the effectiveness of the existing channels of distribution, advertising programmes or media, selling methods and the best way of distributing the goods to the eventual consumers.

An extensive summary of the Deflectable Catheters Market comprises prominent Market that includes several major Market leaders in the report. Deflectable Catheters report provides guidelines about planning of advertising and sales promotion efforts. The business document necessitates an in-depth analysis pertaining to the product manufactured by the vendors combining with the product application range. The competitive landscape section of the report gives a clear insight into the Market share analysis of key industry players. Deflectable Catheters Market report consists of Market attractiveness analysis, wherein each segment is benchmarked based on its Market size, growth rate, and general attractiveness.  

Get a Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-deflectable-catheters-market .

The Global Deflectable Catheters Market to account to USD 2,400.18 Million by 2028 growing at a CAGR of 4.37% in the forecast period of 2021 to 2028.

According to the market report analysis, Deflectable Catheters are used mainly by practitioners in medicine and healthcare. It consists of an elongated catheter body with an electrode placed along the catheter body's distal portion. A tip that can be pulled into a given curve features deflectable catheters. This is done by using a wire attached near the tip to a pull/anchor loop. By controlling one or more pull wires simultaneously, steering is accomplished.

The most significant key factors driving the growth of the Global Deflectable Catheters Market are growing awareness amongst the physicians and patients regarding the benefits of deflectable catheters, Surging volume of patients suffering from cardiovascular disorders, increasing prevalence of geriatric population across the globe, rising usages of advanced material in catheters, increasing adoption of minimally invasive surgical procedures, growing trends of the bi-directional catheters, availability of skilled workforce and installation of state of the art medical instruments and diagnostic equipment.

The major players covered in the Deflectable Catheters Market report are Abbott., BIOCARDIA, INC., Biomerics., Biosense Webster, Inc, Boston Scientific Corporation, CathRx Ltd., Medtronic, OSYPKA AG, Teleflex Incorporated., Johnson & Johnson Services, Inc., Japan Lifeline Co., Ltd., Dynaflex., Merit Medical Systems., BIOTRONIK SE & Co. KG, Duke Extrusion, Creganna, Spectrum Plastics Group, OSCOR Inc, Bendit Technologies., Applied Medical Resources Corporation, among other domestic and global players.

Regional analysis, North America dominates the deflectable catheters market due to the high prevalence of cardiovascular disorders, prevalence of improved healthcare infrastructure, along with an increase in patient awareness about emerging minimally invasive surgeries in the region, while APAC is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the increasing disposable income, rising awareness about emerging healthcare developments in this particular region.

Access Complete Report Here: https://www.databridgemarketresearch.com/reports/global-deflectable-catheters-market .

[speedylightheart]

US Embolotherapy Market Latest Trend, Growth, Size, Application & Forecast 2025

Embolotherapy Market is valued at USD 3125.7 Million in 2018 and expected to reach USD 5461.9 Million by 2025 with the CAGR of 8.30% over the forecast period.

Increasing number of target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement policies are major factors driving the market growth.

Get Sample Copy of The Activated Alumina Market Report 2020@ https://brandessenceresearch.com/requestSample/PostId/552

*The sample pages of this report is immediately accessible on-demand.**

Embolotherapy Market Leading Manufacturer

major players in the Embolotherapy market include,

Boston Scientific Corporation

Merit Medical Systems

Terumo Corporation

Medtronic plc

Johnson & Johnson

Stryker Corporation

BTG plc

Penumbra, Inc

Cook Medical

Abbott Laboratories

Acandis GmbH

BALT Extrusion

Sirtex Medical Limited

Kaneka Corporation

Meril Life Sciences Pvt. Ltd.

Scope of Global Embolotherapy Market Report–

Embolotherapy is a type of endovascular treatment that aims to block abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumors and much more. To achieve blocking, embolotherapy performs minimally-invasive methods and several embolic agents, such as gelfoam, coils, balloons and angiographic catheters to reach exact and significant results. The embolic agents used can be either temporary or permanent and are determined according to the clinical application, and thus can differ greatly from case to case. Embolotherapies have become mainstays of interventional radiology practice. In order to achieve embolotherapy properly, IRs must be qualified, up-to-date on the modern data, aware with fundamental pathologies and well-informed on how other specialties can also contribute to patient treatment.

Global embolotherapy market report is segmented on the basis of product, disease indication, procedure, end-user and region & country level. Based on product, global embolotherapy market is classified into embolic agents, microspheres, embolic coils, liquid embolic agents, embolic plug systems, detachable balloons, support devices, microcatheters and guidewires. Based on disease indication, global embolotherapy market is classified into cancer, liver cancer, kidney cancer, other cancers, peripheral vascular diseases, neurological diseases, cerebral aneurysm, cerebral arteriovenous malformations and fistulas, gastrointestinal disorders, and urological and nephrological disorders. Based on procedure, the market is classified into transcatheter arterial embolization, transcatheter arterial radio embolization/selective internal radiation therapy, and transarterial chemoembolization. Based on end-user, global embolotherapy market is classified into hospitals and clinics, ambulatory surgical centers and others.

The regions covered in this Global Embolotherapy Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Embolotherapy is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Global embolotherapy market report covers prominent players like Boston Scientific Corporation, Merit Medical Systems, Terumo Corporation, Medtronic plc, Johnson & Johnson, Stryker Corporation, BTG plc, Penumbra, Inc., Cook Medical, Abbott Laboratories, Acandis GmbH, BALT Extrusion, Sirtex Medical Limited, Kaneka Corporation, Meril Life Sciences Pvt. Ltd. and others.

Market Dynamic–

Rising incidences of peripheral vascular diseases, liver cancer and strokes, coupled with rising preference for minimally invasive procedures are the major factors driving the market growth. In addition, increasing investments and technological advancements in this field are also supplementing the market growth. According to American Cancer Society, liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. Also, according to the World Health Organization, 15 million people suffer stroke worldwide each year. Out of these, 5 million die and additional 5 million are permanently disabled. However, lack of sufficient evidence & unfavorable regulatory scenario may restrain the growth of the market. Moreover, increasing applications of embolization devices will offer lucrative opportunity for the further growth of the market.

Regional Analysis–

North America is expected to account for the largest market share of the global embolotherapy market during the forecast period. The growing geriatric population, increasing number of ambulatory surgery center (ASCs), and growing preference for minimally invasive surgeries have resulted in the increasing adoption of embolotherapy procedures in this region. According to U.S. department of health and human services, Ambulatory surgery proved to be popular among both physicians and patientsand the number of Medicarecertified ASCs increased steadily, from 239 in 1983 to 5,316 in 2010.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period owing to the large patient population of target diseases, and presence of key market players in the region to grab uplifting opportunities offered by these countries are the key factors supporting the market growth in this region.

Key Benefits for Market Report–

Global Embolotherapy Market report covers in depth historical and forecast analysis.

Global Embolotherapy Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Embolotherapy Market report helps to identify opportunities in market place.

Global Embolotherapy Market report covers extensive analysis of emerging trends and competitive landscape.

Embolotherapy Market Segmentation:–

By Product: -Embolic agents, Microspheres, Embolic coils (Detachable Coils, Pushable Coils), Liquid Embolic Agents, Embolic Plug Systems, Detachable Balloons, Support Devices, Microcatheters, Guidewires

By Disease Indication:- Cancer, Liver Cancer, Kidney Cancer, Other Cancers, Peripheral Vascular Diseases, Neurological Diseases, Cerebral Aneurysm, Cerebral Arteriovenous Malformations and Fistulas, Gastrointestinal Disorders, Urological and Nephrological Disorders

By Procedure:- Transcatheter Arterial Embolization, Transcatheter Arterial Radio embolization/Selective Internal Radiation Therapy, Transarterial Chemoembolization

By End-User:- Hospitals and Clinics, Ambulatory Surgical Centers, Other

By Regional & Country Analysis

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

About Us:

Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at sales@industrystatsreport.com

[adwaitcoherent]

By 2026, Intracranial Stents Market To Surpass US$ 1,143.0 Million - Coherent Market Insights

Intracranial Stents Market To exhibit a CAGR of 15.6% over the forecast period (2018 - 2026).

Request for Sample PDF Copy:

https://www.coherentmarketinsights.com/insight/request-pdf/1870

Description:

Narrowing of the blood vessels or blood clots due to building up of fats, plaque, and other substances in the blood vessels is called intracranial stenosis. This condition marks with a stroke either to the carotid artery in the neck or in an intracranial artery. Stents during this condition act as a permanent implant which allows blood flow to the brain by opening the blocked arteries. Angioplasty (use of balloon catheter) along with placement of a stent may be an appropriate treatment for the patients who have had a stroke or transient ischemic attack (TIA). However, since these stents are designed for use in the heart, it is complex to use them in the arteries of the brain. Though, with the advent of the new self-expanding brain stents, the rate of reoccurrence of artery narrowing can be lowered. For instance, Acclino microstent offered by Acandis GmbH, shows a satisfactory safety profile and a promising rate of immediate and mid-term complete aneurysm occlusion for stent-assisted coil embolization in wide-neck intracranial aneurysms.

 The global intracranial stents market size was valued at US$ 313.5 million in 2017, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).

 Figure 1. Global Intracranial Stents Market Share Analysis (%), By Region, 2017

Intracranial Stents  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2018)

 Intracranial Stents Market Dynamics

 Increasing incidence of stroke and brain aneurysm is propelling demand for intracranial stents. According to the Brain Aneurysm Foundation (BAF), brain aneurysm accounts for around 500,000 deaths worldwide annually. Moreover, BAF estimates that aneurysm is predominant in the age group of 35–60 years. Furthermore, high prevalence of stroke among geriatric population worldwide is also expected to propel demand for intracranial stents in the near future. According to the data published in the Medscape, 2010, around 75-89% of strokes occur in individuals aged > 65 years. Of these strokes, 50% occur in people who are aged ≥ 70 years and nearly 25% occur in individuals who are aged > 85 years.

 Integration of advanced software with existing products are gaining significant traction among various market players of intracranial stents with affordable costs thus, expected to drive intracranial stents market growth. For instance, in September 2016, Medtronic plc received the U.S. Food and Drug Administration (FDA) approval for its StealthStation, which is integrated with Medtronic’s latest O-arm Imaging System, enabling clinicians to place the deep brain stimulation (DBS) leads with high level of accuracy during the cranial procedures.

 However, high cost of the procedure and limited use of various intracranial stents to a small population may impact the overall market to some extent. For instance, in August 2012, the U.S. FDA approved label changes for the Wingspan Stent System offered by Stryker Corporation, reflecting changes in indications for use, and limiting the system to a much smaller group of patients between 22 and 80 years with intracranial stenosis.

 Intracranial Stents Market Regional Outlook

 On the basis of geography, the global intracranial stents market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold dominant position in this market, owing to increasing geriatric population who are more prone to brain diseases and adoption of technologically advanced products such as adoption of cranio maxillofacial implants. Emerging economies are also projected to witness significant growth in market over the forecast period, owing to high prevalence of intracranial strokes. For instance, according to the American Journal of Neuroradiology, 2011, intracranial cerebral atherosclerosis disease (ICAD) accounts for around 8%–10% of all ischemic strokes with a higher reported incidence in the Asian, African, and Hispanic descent populations. The factors responsible for disease prevalence in these regions includes cigarette smoking, hypertension, insulin-dependent diabetes mellitus, and hypercholesterolemia. Thus, emerging economies such as Asia Pacific and Latin America is likely to be the fastest growing region throughout the forecast period.

 Major companies operating in the global intracranial stents market include Medtronic Plc, Balt Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.

About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We do offer wide range of services such as Industry analysis, Consulting services, Market Intelligence, Customized research services and much more. We have expertise in many fields such as healthcare, chemicals and materials, Automation, semiconductors, electronics, energy, food and beverage, packaging and many more. Visit our website to know more.

 Buy Report Here:

https://www.coherentmarketinsights.com/insight/buy-now/1870

Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave.  #3200  Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

[martynnx-blog]

Intracranial Stents Market 2026 Growth Trends by Manufacturers, Regions, Type and Application, Forecast

Narrowing of the blood vessels or blood clots due to building up of fats, plaque, and other substances in the blood vessels is called intracranial stenosis. This condition marks with a stroke either to the carotid artery in the neck or in an intracranial artery. Stents during this condition act as a permanent implant which allows blood flow to the brain by opening the blocked arteries. Angioplasty (use of balloon catheter) along with placement of a stent may be an appropriate treatment for the patients who have had a stroke or transient ischemic attack (TIA). However, since these stents are designed for use in the heart, it is complex to use them in the arteries of the brain. Though, with the advent of the new self-expanding brain stents, the rate of reoccurrence of artery narrowing can be lowered. For instance, Acclino microstent offered by Acandis GmbH, shows a satisfactory safety profile and a promising rate of immediate and mid-term complete aneurysm occlusion for stent-assisted coil embolization in wide-neck intracranial aneurysms.

The global intracranial stents market size was valued at US$ 313.5 million in 2017, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).

Market Dynamics

Factors such as increasing prevalence of brain aneurysms and stroke, government programs to decrease the burden of traumatic brain injury, technological advancements plugging treatment gaps and availability of reimbursement are propelling demand for intracranial stents. However, high cost and stringent government regulations is negatively impacting growth of the market. Companies are therefore, adopting different strategies such as providing FDA approved on-site training, strategic collaborations, and technology upgrades in order to increase their market presence and engage with customers. For instance, in January 2018, Stryker announced the positive results of WEAVE, the post market surveillance study of the company’s Wingspan stent system, for the patients suffering from intracranial atherosclerotic disease (ICAD). Thus, providing more opportunities in procedural approach with significant results.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1870

Intracranial Stents Market Regional Outlook

On the basis of geography, the global intracranial stents market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to hold dominant position in this market, owing to increasing geriatric population who are more prone to brain diseases and adoption of technologically advanced products such as adoption of cranio maxillofacial implants. Emerging economies are also projected to witness significant growth in market over the forecast period, owing to high prevalence of intracranial strokes. For instance, according to the American Journal of Neuroradiology, 2011, intracranial cerebral atherosclerosis disease (ICAD) accounts for around 8%–10% of all ischemic strokes with a higher reported incidence in the Asian, African, and Hispanic descent populations. The factors responsible for disease prevalence in these regions includes cigarette smoking, hypertension, insulin-dependent diabetes mellitus, and hypercholesterolemia. Thus, emerging economies such as Asia Pacific and Latin America is likely to be the fastest growing region throughout the forecast period.

Major Key Players:

Major companies operating in the global intracranial stents market include Medtronic Plc, Balt Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.

[dutchcatheters]

At Dutch Technology Catheters, you will get high quality and high-performance medical balloons having the thinnest walls, highest blood pressure, and unique balloon design options. Offering a wide selection includes distinct balloon material, simple to complex shapes, and ends.

[pratikshame-blog]

Medical Plastics Market : Industry Outlook by 2027

The global medical plastics market was valued at US$ 9.1 Bn in 2018 and is anticipated to expand at a CAGR of 7.2% from 2019 to 2027, according to a new research report titled ‘Medical Plastics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’’ published by Transparency Market Research (TMR).

Rise in demand for medical plastics for manufacturing medical devices fuels the global medical plastics market. North America accounts for a major share of the global medical plastics market due to the increase in usage of medical plastics in disposable medical devices

Increasing Demand for Plastics in Medical Industry

Increase in demand for plastics to manufacture medical devices such as disposables, diagnostic instruments, catheters, tubes, masks, and medical bags is anticipated to boost the global medical plastics market. Lightweight and cost-effectiveness of medical plastics attract large number of medical device manufacturers to invest in medical plastics.

Rising demand for disposable medical devices such as bed pens, inhalation masks, and intravenous (IV) tubes is likely to propel the medical plastics market during the forecast period. Low density of medical plastics make them ideal for the use in applications such as orthopedic devices, artificial cornea, and hearing aids. Implementation of stringent regulations by governing bodies across the globe is expected to reduce the consumption of medical plastics owing to health concerns. Long shelf life of medical plastics is a major factor driving the demand for these plastics.

Advancements in 3D Printing Technologies for Manufacturing Medical Devices

Adoption of advanced technologies such as 3D printing is a key factor fuelling the global medical plastics market. 3D printing is used to create tissues & organoids, surgical tools, patient-specific surgical models, and customized prosthetics. The usage of 3D printing technology can help customize medical implants for body parts such as knees, hips, ankles, parts of spine, and skull.

Sterile instruments such as forceps, hemostats, scalpel handles, and clamps can be manufactured using 3D printing technology. 3D printing enables rapid production of dental implants, hearing aids, prescription eyeglasses, and headgear.

High Focus on Extrusion Process Technology

Extrusion is a process of making different parts, which have continuous length and cross section. Plastic in the form of solid plastic mass, pellet, or powder and foaming agents are extensively mixed, melted, and pushed through a die to form a shape during the extrusion process. The obtained shape is moved through secondary operations where it is cooled and cut into required shapes. Extrusion is preferred to other molding technologies for the manufacturing of structures with varying geometries.

North America Dominates Global Medical Plastics Market

In terms of demand, North America is expected to hold dominant share of the global medical plastics market during the forecast period. Increase in geriatric population and penetration of lifestyle diseases are the major factors fuelling the medical plastics market in the region. Major manufacturers such as BASF SE, Dow DuPont, and Evonik Industries AG have operational units in the region.

Substantial investments in research and development and supportive government initiatives are further driving the medical plastics market in North America. According to the survey conducted by Research America, the investment in medical and health care development in the U.S. rose by 20.6% between 2013 and 2016. Rise in investments in R&D activities in the health care sector is likely to propel the demand for medical plastics in North America.

High Degree of Competition among Established Players

The global medical plastics market is highly fragmented. Therefore, intense competition exists in the market. Major players operating in the global medical plastics market adopt various strategies such as mergers, acquisitions, partnerships, and product launches in order to strengthen their position. Suppliers of medical plastics focus on forward integration in order to achieve product differentiation.

To obtain all-inclusive information on forecast analysis of Medical Plastics Market , request a PDF brochure here.

Key players profiled in the report on the global medical plastics include Exxon Mobil Corporation, BASF SE, Dow DuPOnt, Evonik Industries AG, Arkema S.A, Covestro AG, Royal DSM, Solvay, The Lubrizol Corporation, HMC Polymers, and Eastman Chemical Company.

[jayu123-me]

Medical Plastics Market :Use of Plastic Bags within Medicine

The presence of an ever-expanding healthcare industry is behind the growth of the global medical plastics market. There is tremendous demand for improved medical engineering, majorly due to the need for faster extrusion and intravenous procedures. The relevance of medical plastics during surgical procedures is tremendous. The need for ensuring proper planning and execution of surgeries has created humongous demand within the global medical plastics market. Availability of improved plastics, ranging across PE, PVC, and PP materials, has generated greater trust across the medical fraternity. Henceforth, it is safe to project that the global medical plastics market would amass a starry volume of revenues.

Transparency Market Research (TMR), in a custom report, finds that the global medical plastics market would expand at a CAGR of 7.2% over the period between 2019 and 2027. Furthermore, the total value of the medical plastics market is expected to touch US$ 15.4 Bn by 2027.

Request A Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11150

Advancements in Dentistry

The field of dentistry has emerged as a lucrative area within medicine. The willingness of the masses to spend a substantial part of their income on dental treatment offers new opportunities for several medical manufacturers. The use of medical plastics for development of dentures and storage of dental cements has played a key role in the growth of the global market. Furthermore, plastic disposables have gained popularity across the healthcare industry. The need for cleanliness and hygiene has generated humongous demand for plastic disposable bags. Therefore, the total value of the global medical plastics market is slated to touch new heights in the years to follow.

Use of Plastic Bags within Medicine

Despite the growing relevance of medical plastics, the market could be affected by increasing flak against non-biodegradable products. Medical waste contributes towards environmental pollution, and the industry is under constant scrutiny from government authorities and state bodies. However, the efforts of the healthcare industry towards proper disposal of wastes is a sound strategy for development. Therefore, the global medical plastics market could thrive on account of the resilience and seriousness shown by medical bodies towards waste disposal. Use of catheters and syringes for a variety of treatments within healthcare has also pushed market growth.

Browse Press Release@https://www.transparencymarketresearch.com/pressrelease/medical-plastics-market.htm

The applications of plastics within the healthcare industry span into a variety of areas. The use of plastic bags is a basic necessity across medical wards and operation theatres. Furthermore, the need for storing sharp surgical instruments is also met through plastic containers and boxes. The need for safety within the healthcare industry has led to the use of medical plastics. The profit margins of the vendors operating in the global medical plastics market are slated to widen.

Some of the leading players in the global medical plastics market are Exxon Mobil Corporation, Dow DuPont, BASF SE, Celanese Corporation, and The Lubrizol Corporation.

[marketnewzstack-blog]

Angiographic Catheter Market Report 2019 | Global Growth Opportunities Forecast Of Industry By 2024

The Recently Published "Angiographic Catheter Market" report includes – Forecasted Industry Future Trends, Expansion Opportunity, and Our Professional Experts reviews and forecast term (2019-2024). Also, Angiographic Catheter Market Report consist of a Large range of Utilization Ratio and Applications, Demand and Supply assessment also consists of the Report. The report includes SWOT analysis, investment feasibility analysis Porter Five Force analysis and also at the end Parts report introduced new projects.

Global Angiographic Catheter Market Report Sample PDF Request Link is Here: https://market.biz/report/global-angiographic-catheter-market-2018-mr/313374/#requestforsample

Competitive Landscape Framed in the Global Angiographic Catheter Market Report:

1. The local and also universe level Market share Assessments.

2. The latest technological advancements included with help of Supply chain Mapping.

3. Strategic assessment on the basis of Key Drivers and restraints Analysis, Product or Technology Analysis, SWOT analysis,  and also Porter's five forces analysis are carried out.

The Potential Competitors as well as the Growth Drivers of the Angiographic Catheter Market Report:

Merit Medical Systems Balt Extrusion AngioDynamics Shangyi Kangge Medical Micro Port Medtronic Boston Scientific Corporation Curative Medical Devices GmbH Cook Incorporated Cordis Corporation B. Braun Terumo

Most common Types of Angiographic Catheter: Non Selective ABCD, Selective ABCD

Important Applications of Angiographic Catheter: Hospitals, Clinics

Global Angiographic Catheter Market segmentation on Regions as well as Countries level, this report covers Regions such as:

North America Country (United States, Canada)

South America

Asia Country (China, Japan, India, Korea)

Europe Country (Germany, UK, France, Italy)

Also Other Countries (Middle East, Africa, GCC)

Also, Feel Free Ask Any Query or Inquiry Regarding Report@ https://market.biz/report/global-angiographic-catheter-market-2018-mr/313374/#inquiry

About us:

The Report on Global Angiographic Catheter Market 2019 is Published by Market.Biz

Market.Biz provides the best research and Information required to all industrial, commercial, and profit-making ventures of any sector in online business. Our Report is also a well-estimated because we refer to Press Releases, Authorized Government papers, Properly verified White documents, True Financial Reports, Investor Information, and Industry Interviews. We Also analyze to identify new trends and new growth and provide all of this information in a report focused on your market.

Most Trending Reports of Market.Biz:

Global Electroscopes Industry Market Research Report

[trendingnewz-blog]

Medical Plastics Market to Reach US$ 15.4 Bn by 2027

The global medical plastics market was valued at US$ 9.1 Bn in 2018 and is anticipated to expand at a CAGR of 7.2% from 2019 to 2027, according to a new research report titled ‘Medical Plastics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’’ published by Transparency Market Research (TMR). Rise in demand for medical plastics for manufacturing medical devices fuels the global medical plastics market. North America accounts for a major share of the global medical plastics market due to the increase in usage of medical plastics in disposable medical devices

 Increasing Demand for Plastics in Medical Industry

 Increase in demand for plastics to manufacture medical devices such as disposables, diagnostic instruments, catheters, tubes, masks, and medical bags is anticipated to boost the global medical plastics market. Lightweight and cost-effectiveness of medical plastics attract large number of medical device manufacturers to invest in medical plastics. Rising demand for disposable medical devices such as bed pens, inhalation masks, and intravenous (IV) tubes is likely to propel the medical plastics market during the forecast period. Low density of medical plastics make them ideal for the use in applications such as orthopedic devices, artificial cornea, and hearing aids. Implementation of stringent regulations by governing bodies across the globe is expected to reduce the consumption of medical plastics owing to health concerns. Long shelf life of medical plastics is a major factor driving the demand for these plastics.

 Are you a start-up willing to make it big in the business? Grab an exclusive PDF sample of this report here

  Advancements in 3D Printing Technologies for Manufacturing Medical Devices

 Adoption of advanced technologies such as 3D printing is a key factor fuelling the global medical plastics market. 3D printing is used to create tissues & organoids, surgical tools, patient-specific surgical models, and customized prosthetics. The usage of 3D printing technology can help customize medical implants for body parts such as knees, hips, ankles, parts of spine, and skull. Sterile instruments such as forceps, hemostats, scalpel handles, and clamps can be manufactured using 3D printing technology. 3D printing enables rapid production of dental implants, hearing aids, prescription eyeglasses, and headgear.

 High Focus on Extrusion Process Technology

 Extrusion is a process of making different parts, which have continuous length and cross section. Plastic in the form of solid plastic mass, pellet, or powder and foaming agents are extensively mixed, melted, and pushed through a die to form a shape during the extrusion process. The obtained shape is moved through secondary operations where it is cooled and cut into required shapes. Extrusion is preferred to other molding technologies for the manufacturing of structures with varying geometries.

 Is something restraining your company’s growth in the “XYZ” market? Ask for the report brochure here

 North America Dominates Global Medical Plastics Market

 In terms of demand, North America is expected to hold dominant share of the global medical plastics market during the forecast period. Increase in geriatric population and penetration of lifestyle diseases are the major factors fuelling the medical plastics market in the region. Major manufacturers such as BASF SE, Dow DuPont, and Evonik Industries AG have operational units in the region. Substantial investments in research and development and supportive government initiatives are further driving the medical plastics market in North America. According to the survey conducted by Research America, the investment in medical and health care development in the U.S. rose by 20.6% between 2013 and 2016. Rise in investments in R&D activities in the health care sector is likely to propel the demand for medical plastics in North America.

 Stuck in a neck-to-neck competition with other brands? Request a custom report on competition on “XYZ market” here

  High Degree of Competition among Established Players

 The global medical plastics market is highly fragmented. Therefore, intense competition exists in the market. Major players operating in the global medical plastics market adopt various strategies such as mergers, acquisitions, partnerships, and product launches in order to strengthen their position. Suppliers of medical plastics focus on forward integration in order to achieve product differentiation. Key players profiled in the report on the global medical plastics include Exxon Mobil Corporation, BASF SE, Dow DuPOnt, Evonik Industries AG, Arkema S.A, Covestro AG, Royal DSM, Solvay, The Lubrizol Corporation, HMC Polymers, and Eastman Chemical Company.

    About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey

Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

Tel:

 +1-518-618-1030

USA - Canada Toll Free:

 866-552-3453

Email:

sales@transparencymarketresearch.com

Website:

http://www.transparencymarketresearch.com

Research Blog:

http://www.europlat.org/